Shinva Medical Instrument Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,111	3,095	2,945	3,188	1,689	1,567
Short-Term Investments	-	-	-	-	-	10
Trading Asset Securities	-	-	1.03	100.1	100.31	98.07
Cash & Short-Term Investments	3,111	3,095	2,946	3,288	1,789	1,675
Cash Growth	19.10%	5.06%	-10.42%	83.78%	6.81%	20.32%
Accounts Receivable	2,198	2,295	2,306	2,110	2,004	1,772
Other Receivables	408.75	327.47	461.42	238.49	235.97	181.24
Receivables	2,607	2,623	2,768	2,348	2,240	1,953
Inventory	2,791	2,903	3,356	3,556	3,029	2,306
Prepaid Expenses	-	-	2.02	0.18	0.07	0.01
Other Current Assets	310.45	272.69	294.27	261.95	327.01	243.2
Total Current Assets	8,819	8,894	9,366	9,454	7,385	6,177
Property, Plant & Equipment	3,248	3,269	3,181	3,013	2,526	2,396
Long-Term Investments	1,254	1,367	1,640	1,787	1,712	1,684
Goodwill	242.04	242.04	242.04	257.26	268.76	268.76
Other Intangible Assets	444.18	447.2	469.87	478.06	478.53	461.25
Long-Term Accounts Receivable	-	-	9.38	14.78	1.37	28.92
Long-Term Deferred Tax Assets	125.61	129.35	122.45	115.96	90.34	69.66
Long-Term Deferred Charges	124.52	123.54	123.24	123.33	132.28	148.63
Other Long-Term Assets	451.21	347.24	373.08	346.4	366.56	378.67
Total Assets	14,708	14,820	15,526	15,590	12,961	11,614
Accounts Payable	2,696	2,532	2,754	2,443	2,497	2,193
Accrued Expenses	271	321.21	440.29	508.64	450.4	333.52
Short-Term Debt	919.09	925.14	900.61	871.95	986.4	926.39
Current Portion of Long-Term Debt	-	120.37	107	28.47	59.23	94.32
Current Portion of Leases	-	-	17.98	22.82	21.39	17.34
Current Income Taxes Payable	-	87.69	39.37	31.96	32.63	67.47
Current Unearned Revenue	1,471	1,649	2,049	2,336	2,042	1,761
Other Current Liabilities	888.46	912.07	928.1	1,254	817.42	627.9
Total Current Liabilities	6,245	6,547	7,237	7,498	6,906	6,021
Long-Term Debt	123.65	90.57	80.48	137.8	96.33	58.66
Long-Term Leases	59.05	48.82	29.83	37.95	29.37	89.77
Long-Term Unearned Revenue	81.49	77.92	78.76	61.67	52.62	53.69
Long-Term Deferred Tax Liabilities	97.26	95.85	94.87	96.04	82.75	116.04
Other Long-Term Liabilities	1.46	1.73	22.77	39.44	6.4	6.4
Total Liabilities	6,608	6,862	7,544	7,870	7,174	6,345
Common Stock	606.64	606.68	606.68	466.68	411.97	406.43
Additional Paid-In Capital	2,497	2,497	2,716	3,000	1,723	1,667
Retained Earnings	4,687	4,563	4,324	3,867	3,283	2,838
Treasury Stock	-	-17.74	-37.8	-60.28	-62.46	-
Comprehensive Income & Other	-11.8	-15.35	-11.41	45.08	35.49	3.48
Total Common Equity	7,779	7,634	7,597	7,319	5,391	4,915
Minority Interest	320.82	323.15	385.5	401.21	396.27	353.72
Shareholders' Equity	8,100	7,957	7,983	7,720	5,787	5,268
Total Liabilities & Equity	14,708	14,820	15,526	15,590	12,961	11,614
Total Debt	1,102	1,185	1,136	1,099	1,193	1,186
Net Cash (Debt)	2,009	1,910	1,810	2,189	596.64	488.82
Net Cash Growth	37.07%	5.54%	-17.34%	266.96%	22.06%	-
Net Cash Per Share	3.29	3.16	2.98	3.65	1.13	0.93
Filing Date Shares Outstanding	620.29	610.31	606.68	606.69	606.94	535.57
Total Common Shares Outstanding	620.29	610.31	606.68	606.69	535.57	528.36
Working Capital	2,574	2,346	2,129	1,957	478.72	156.3
Book Value Per Share	12.54	12.51	12.52	12.06	10.07	9.30
Tangible Book Value	7,093	6,945	6,885	6,583	4,644	4,185
Tangible Book Value Per Share	11.43	11.38	11.35	10.85	8.67	7.92
Buildings	-	-	2,711	2,148	2,114	2,071
Machinery	-	-	1,357	1,351	1,212	1,117
Construction In Progress	-	-	466.9	739.97	304.46	122.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.